Related Experiment Video
Updated: Jul 29, 2026
11:01
Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase
Published on: November 23, 2016
A potent polymer/pyridoxamine enzyme mimic
1Department of Chemistry, Columbia University, New York, New York 10027, USA.
Journal of the American Chemical Society
|May 2, 2002
Summary
Researchers developed an enzyme mimic using pyridoxamine and polyethyleneimine to convert pyruvic acid to dl-alanine. This novel catalyst showed an 8000-fold acceleration, demonstrating its potential in synthetic chemistry.
Area of Science:
- Biomimetic Chemistry
- Catalysis
- Polymer Science
Background:
- Transamination reactions are crucial in biological systems.
- Pyridoxamine is a known catalyst for transamination but often requires optimization for efficiency.
- Developing efficient synthetic mimics of enzymes is a key goal in catalysis research.
Purpose of the Study:
- To create a highly active enzyme mimic for the conversion of pyruvic acid to dl-alanine.
- To investigate the effect of polymer structure on catalytic activity.
- To understand the role of polymer-bound acid-base groups in catalysis.
Main Methods:
- Covalent linkage of pyridoxamine to polyethyleneimine.
- Functionalization of polyethyleneimine with long-chain alkyl groups.
- Assay of the enzyme mimic's catalytic activity in converting pyruvic acid to dl-alanine.
Main Results:
- The enzyme mimic achieved up to an 8000-fold acceleration compared to simple pyridoxamine.
- Catalytic acceleration was highly dependent on the length of the appended alkyl chains.
- The polymer provided essential acid and base groups for catalyzing proton transfers.
Conclusions:
- Polymer-supported pyridoxamine derivatives can act as potent enzyme mimics.
- Alkyl chain length is a critical factor in optimizing the catalytic efficiency of these mimics.
- This approach offers a promising strategy for designing efficient synthetic catalysts for transamination.
More Related Videos
Related Concept Videos
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:26Physical Properties of Amines
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...